- MOTS Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
Motus GI (MOTS) CORRESPCorrespondence with SEC
Filed: 18 Dec 23, 12:00am
December 18, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Motus GI Holdings, Inc. (the “Company”) |
Registration Statement on Form S-1 (File No. 333-275121) |
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 5:00 p.m., Eastern Time, on December 18, 2023, or as soon as practicable thereafter.
Please call Steven M. Skolnick of Lowenstein Sandler LLP at 973-597-2476 to confirm the effectiveness of the Registration Statement or with any questions.
Very truly yours, | ||
SONNET BIOTHERAPEUTICS HOLDINGS, INC. | ||
By: | /s/ Mark Pomeranz | |
Name: | Mark Pomeranz | |
Title: | Chief Executive Officer |